Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with …

G Ferrera, M Cuccia, G Mereu, G Icardi… - Human vaccines & …, 2012 - Taylor & Francis
Background: Pertussis occurs in older children, adolescents and adults due to waning
immunity after primary vaccination. Booster vaccination for pre-school children has been …

A randomised controlled trial with a diphtheria–tetanus–acellular pertussis (dTpa) vaccine in adults

M Van der Wielen, P Van Damme, E Joossens… - Vaccine, 2000 - Elsevier
The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …

Booster vaccination of adults with reduced-antigen-content diphtheria, tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination

PB McIntyre, MA Burgess, A Egan, L Schuerman… - Vaccine, 2009 - Elsevier
At 60 months post-vaccination, adults (mean age 45.6 years) randomised to receive
combined reduced-antigen-content diphtheria–tetanus and acellular pertussis vaccine …

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine

PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
There is increasing interest in prevention of pertussis in adults by vaccination, but little is
known about the duration of the antibody response to pertussis, diphtheria or tetanus in …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …

R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults

J Mertsola, O Van Der Meeren, Q He… - Clinical Infectious …, 2010 - academic.oup.com
Background. Booster vaccination against tetanus and diphtheria at 10-year intervals is
commonly recommended. Reduced antigen content diphtheria and tetanus toxoids and …

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane …

G Kanra, M Ceyhan, D Vandevoorde… - European journal of …, 1993 - Springer
In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccine (dTpa) administered as a booster to 4–6 year-old …

P Kosuwon, B Warachit, Y Hutagalung, T Borkird… - Vaccine, 2003 - Elsevier
A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

Safety and immunogenicity of combined DTPa-IPV vaccine for primary and booster vaccination

S Meriste, E Tamm, P Willems… - Scandinavian journal of …, 1999 - Taylor & Francis
This study evaluated the safety and immunogenicity of combined diphtheria, tetanus,
acellular pertussis, inactivated poliomyelitis vaccine (DTPa-IPV) given as primary …

A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults

FM Turnbull, TC Heath, BB Jalaludin, MA Burgess… - Vaccine, 2000 - Elsevier
A single blinded randomized controlled trial to compare the reactogenicity and
immunogenicity of adult formulated dTpa and monovalent pa vaccines with a licensed Td …